NPP for imported cancer drugs
Drugs for Blood Disorders
Alleviare promptly facilitates Indian patients and physicians under Named Patient Programs (NPP) to access imported authorized medicines that are not locally available to them.
Get access to an unapproved drug for personal use.
Here is a list of some of the Drugs for Blood Disorders for which we currently have a NPP in place. If you are a patient or healthcare professional, please click below on each to access details and information.
ULTOMIRIS (ravulizumab-cwvz) injection
REBLOZYL (luspatercept-aamt) for injection
APHEXDA (motixafortide) for injection
Aranesp (darbepoetin alfa) injection
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
Access Under Named Patient Programs
Specialty Drugs
Here is a list of some of the products for which we currently have a NPP in place. If you are a patient or healthcare professional, please click below on each to access details and information.
Lanadelumab For Injection
Valbenazine Capsules
Letermovir Injection
Olaratumab Injection
Query Form
We would love to speak with you.
Feel free to reach out using the below details.
Access Unauthorized Medicines In India Under NPP.
List of imported cancer medicines can be accessed under Named Patient Programs (NPP)
What is Named-patient access programme (NPP)?
Named-patient basis access can also refer to a medicine for a specific patient or patients that is not (yet) authorised and available to them in their own country. Such medicine should or must (depending on legislation) be authorised in at least one country, from which it can be imported into the patient’s country under a Named-patient access programme (NPP).
These may be medicines that are:
- Authorised but not yet available to be prescribed in the patient’s country.
- Authorised and available in one country but not authorised and available in the patient’s country.
- Discontinued in the patient’s country but not in another country.
- In shortage in the patient’s country but not in another country.
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Get Access to an Unapproved Drug
For personal use, get access to an imported medicines (unapproved drug in India) for Blood Disorders. On request, Anti-cancer medicines can be imported to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.